Duration of Active Symptoms and Stigma Among Patients of Schizophrenia: A Cross-Sectional Study.

Main Article Content

Vaishal Dushyant Chokshi
Parth Dharmesh Shah
Bhaveshkumar M Lakdawala
Jignesh chandra Chaudhary

Abstract

Introduction
Schizophrenia is a chronic condition requiring long term medications with serial compliance by patients. Stigma is an important factor which affects recovery and compliance of patients with schizophrenia. Stigma may be perceived stigma , self-stigma or experienced stigma .
AIMS AND OBJECTIVES  :
To  study soico-demographic factors of patients diagnosd with schizophrenia .
To study correlation between duration of active illness and stigma among patients of schizophrenia .
RESULTS
The value of pearson’s correlation co-efficient R is 0.3497, thus indicating a ppositive correlation between duration of active illness and  stigma faced by the patients. P value for pearson’s correlation was found out to be 0.01188 which is statistically significant at p<0.05.
CONCLUSION
It thus becomes of utmost importance for early diagnosis , treatment of Schizphrenia , not only by medications , but also through a bio-psycho-social approach .

Stigma may affect recovery , promote relapse and treatment reisistance and it has become more important then ever to address this evil vice

Article Details

How to Cite
Vaishal Dushyant Chokshi, Parth Dharmesh Shah, Bhaveshkumar M Lakdawala, & Jignesh chandra Chaudhary. (2023). Duration of Active Symptoms and Stigma Among Patients of Schizophrenia: A Cross-Sectional Study. Journal of Coastal Life Medicine, 11(2), 583–586. Retrieved from https://www.jclmm.com/index.php/journal/article/view/1052
Section
Articles

References

Kempinski A. Schizophrenia. Warszawa; PZWL: 2012. ss.400. ISBN 978- 83-77200-506.

Link, B.G., Phelan, J.C., 2006. Stigma and its public health implications. Lancet 9509, 528–529.

Orfanos S, Banks C, Priebe S. Are group psychotherapeutic treatments effective for patients with schizophrenia? A systematic review and metanalysis. PsychotherPsychosom. 2015;84(4):241–249.

Brohan E, Slade M, Clement S, Thornicroft G. Experiences of mental illness stigma, prejudice and discrimination: a review of measures. BMC health services research. 2010 Dec;10(1):80

Van Brakel WH, Anderson AM, Mutatkar RK, Bakirtzief Z, Nicholls PG, Raju MS, et al: The Participation Scale: measuring a key concept in public health. Disability and Rehabilitation 2006, 28:193-203

Corrigan PW. The impact of stigma on severe mental illness. Cognitive and behavioral practice. 1998 Dec 1;5(2):201-22

Adewuya AO, Makanjuola RO. Subjective quality of life of Nigerian schizophrenia patients: sociodemographic and clinical correlates. Acta Psychiatrica Scandinavica.2009 Aug;120(2):160-4

Caltaux D. Internalized stigma: a barrier to employment for people with mental illness. British Journal of Therapy and Rehabilitaiton. 2003 Dec;10(12):539-44

Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: psychometric properties of a new measure. Psychiatry research. 2003 Nov 1;121(1):31-49.